Press Room

Always up to Date

We invite you to get to know Raumedic better. In our press section, you will find current press releases as well as background information about the company and its different business areas. Here, we provide the most important facts and figures. If you would like to learn more about us, we kindly ask you to have a look at our company pages

We are pleased to help media representatives with all issues around Raumedic. You need further images, are researching about one of our areas of expertise, would like to submit a filming request or want to register for our press distribution list? Then simply contact us.

Representative for Public Relations

Dominik Bauer

Tel. +49 9252 359-1453


Tallinn, Estonia – A&G AS, based in the Estonian capital of Tallinn, has been part of the Raumedic group of companies since 2021. It has now been…

Helmbrechts – Today, Raumedic has announced a comprehensive rebranding. The new company concept forms the core of the brand. The new brand is visually…

Helmbrechts - Raumedic AG supports the Helmbrechts volunteer fire brigade with a donation of 2.500 euros. On Monday, February 21, 2022, Dominik Bauer,…



Human health is at the core of Raumedic Group's business. The company specializes in processing medical-grade thermoplastic polymers and silicones at six production sites in Europe and the United States.

As a partner of the international medical technology and pharmaceutical industry, the polymer specialist develops and produces customized components for customers, including tubing, catheters and molded parts as well as complex groups of components and systems for diagnostic and therapeutic uses. For the clinical areas of neuro-monitoring and traumatology, Raumedic produces high-precision pressure-measuring systems with microchip technology. In doing so, it plays a key role in safe patient care around the world.

With 70 years of experience in the areas of extrusion, injection molding and assembly, the company with a global workforce of 1,000 people turns customer ideas into mature products. The foundation of this work is formed by a quality management system based on ISO 13485 and clean room manufacturing on an area of 107,000 square feet (10,000 square meters) based on ISO 14644 (class 7).

Its global sales network and its own distribution companies in core markets ensure that medical and pharmaceutical customers as well as end users in hospitals and doctors’ offices have a high level of product availability at all times.

Important milestones

  • 1948 – Founding of today’s sister company Rehau AG + Co.
  • 1957 – First German heart surgery with Raumedic tubing
  • 1971 – Official registration of the brand name “Raumedic”
  • 1978 – First automation in the field of injection molding
  • 1996 – Entry into microchip technology
  • 2001 – Installation of a 4-layer micro extrusion line
  • 2004 – Spin-off of Raumedic as a new company with 240 employees
  • 2014 – Expansion of production and office areas at the headquarters in Helmbrechts
  • 2015 – Construction of new development and production facilities in the USA
  • 2016 – Start of production in Mills River, North Carolina, USA
  • 2018 – Construction of a modern customer center at the German headquarters
  • 2021 – The assembly company A&G from Tallinn (Estonia) joined the RAUMEDIC family

Executive Board RAUMEDIC AG

Stefan Seuferling
Chairman of the Executive Board & Chief Executive Officer

Following various positions with international medical technology companies, Stefan Seuferling joined RAUMEDIC AG in 2018 as Member of the Executive Board. In March 2019, he was appointed Chairman of the Executive Board and Chief Executive Officer (CEO) of RAUMEDIC AG. Since 2022 he is also responsible for RAUMEDIC Inc. as Chairman of the Board of Directors.

Martin Schenkel
Member of the Executive Board & Chief Operating Officer

Martin Schenkel started his RAUMEDIC career in 2004 as a production manager at the Feuchtwangen plant. In 2009, his scope of responsibility expanded to include plant management in Zwönitz and Helmbrechts. Since 2018, the Chief Operating Officer (COO) has also been a member of the Executive Board of RAUMEDIC AG.

Thomas Knechtel
Member of the Executive Board & Chief Technology Officer

Thomas Knechtel joined the company in 2009. Beginning in 2016, he headed the Systems Business Unit. In 2018, he was appointed to the Executive Board, and since 2021 he is CTO of RAUMEDIC AG.

Daniel Seibert
Member of the Executive Board & Chief Financial Officer

CFO Daniel Seibert has been working for RAUMEDIC AG since April 2019. The graduate in business management has about 30 years of professional experience, which he has acquired in medium-sized companies as well as in international corporations.

Facts & Figures


Media Library & Events

BIOMEDevice Boston

Wearable Injectors & Connected Devices

Congrès international A3P